Transcranial Magnetic Stimulation as a Treatment for Postpartum Obsessive Compulsive Disorder

Starting soon · Not applicable

Conditions studied: Postpartum Obsessive Compulsive Disorder

In brief

The goal of this clinical trial is to learn if accelerated transcranial magnetic stimulation (TMS) is a feasible treatment for obsessive compulsive disorder that worsens or starts within 12 months of childbirth. The main questions it aims to answer are: Is TMS a tolerable and acceptable treatment for postpartum women with OCD? Does TMS improve OCD symptoms in postpartum women? Does TMS change connectivity between areas of the brain involved in OCD? Participants will: 1. Receive 50 sessions of a type of TMS called continuous theta burst stimulation (cTBS) over the course of two weeks. 2. Complete clinical assessments before and after TMS, as well as at 1 and 3 months post-treatment 3. Undergo functional magnetic resonance imaging (fMRI) of the brain before and after TMS

Key facts

Study ID

NCT07571187

Run by

Butler Hospital

People needed

15

Starts

2026-04-01

Expected to finish

2028-06-01

Last updated by the study team

2026-05-06

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Age 18-45
• Diagnosis of OCD defined by DSM-V criteria with problematic symptoms in the 12 months following childbirth
• YBOCS ≥16
• Either currently taking OCD medications at a stable dose for 8 weeks or unmedicated
• Concurrent psychotherapy (exposure and response prevention therapy) will be allowed if it was initiated 8 weeks or more before study entry and continues regularly throughout the trial
• Ability to read, write and understand English sufficiently well to complete study procedures and provide informed consent.

You may not qualify if…

• Past history of a primary psychotic or bipolar disorder
• Current acute suicidality or significantly elevated risk of suicide as determined by the investigators
• Personal history of moderate traumatic brain injury, epilepsy, or other clinically significant neurological illness except tic disorders
• A history of pre-eclampsia during the most recent pregnancy if the patient is less than 8 weeks postpartum
• Current, moderate to severe alcohol or illicit substance use disorder in the last 3 months, determined by clinical assessment
• Women who are currently pregnant. All participants will be asked to use a reasonable birth control method throughout the study period (barrier, oral contraceptives, etc.). We will not administer pregnancy tests.
• current psychotic symptoms
• A current seizure disorder
• active severe major depressive episode as indicated on the Edinburgh Postnatal Depression Scale (greater than or equal to 19).

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.